X
UK pharma concedes defeat on NHS drug cost controls
https://pharmaphorum.com/news/uk-pharma-concedes-defeat-nhs-drug-cost-controls/
Budget Impact Test
NHS supremo hails Alexion and Roche deals, but defends budget controls
Simon Stevens hails success in negotiating with pharma companies on price and data, and has defended NHS England’s record in promoting innovative medicines.
Ultra-rare disease drugs: has access in England just got harder?
Gaining access to ultra-orphan drugs could become much more difficult.
Pharma could take NHS England to court over new delaying tactics
New cost-capping and delaying measures will further restrict access to new medicines say pharma and patient groups.
Pharma criticises ‘heavy handed’ NICE affordability test
NHS England and NICE are attempting to reduce budget impact of drugs.
The budget impact of new medicines
What could be the impact of proposed new ‘budget impact threshold’ for drugs?